/Investor DB

Possible Ventures — 2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

Coherence Neurocoherenceneuro.comin𝕏Nov 2025 · $10M

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.

AI & Machine LearningBiotechMedical DevicesSan Francisco, US

Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in

Co-investorsArtesianASDF VenturesBlackbird VenturesDivergent CapitalEmpath VenturesIrregular Expressions+5 more

enaDyneenadyne.deinSeed · Sep 2025 · $8M

enaDyne develops a plasma-based CO2 recycling technology that reduces emissions while producing sustainable raw materials.

CleantechClimate TechNew Materials

Philipp Hahn(Co-Founder und CEO)inChristian Koch(CTO)in

Co-investorsAmadeus Capital PartnersAPEX VenturesEnergy Capital VenturesSpinLabAntares Ventures Pte. Ltd.

Heidi Healthheidihealth.com.auin𝕏Mar 2025

Heidi builds an AI Care Partner platform that augments clinical workflows through an AI scribe and a medical research tool called Evidence, serving clinicians across hospitals and healthcare systems globally.

AI & Machine LearningDigital HealthHealthtechSaaS

Dr. Thomas Kelly MDWaleed Mussa(Founder)inThomas Kelly(Founder)Yu Liu(Founder)

Co-investorsHeadlineLatitudeAlumni VenturesArchangel VenturesBlackbird VenturesGeneral Catalyst+7 more

SWARM Biotacticsswarm-biotactics.cominSeed · Jun 2025 · $12M

SWARM Biotactics develops bio-robotic cyborg swarms of living organisms equipped with sensors, edge AI, and secure communications, controlled through its SWARM OS orchestration platform for command, autonomy, and sensor fusion.

AI & Machine LearningDefense TechRobotics

Stefan Wilhelm(Founder)inJan Peter Schween(Founder)Jörg Lambrecht(Founder)Moritz Strube(Founder)

Co-investorsCapnamicVertex VenturesVertex Ventures Sea Management Pte. Ltd.

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ViridiCO2

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.